NRBO NeuroBo Pharmaceuticals 8-K2021Regulation FD Disclosure
8 Jan 21
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
NRBO 8-K Filings
- 13 Jan 21 Departure of Directors or Certain Officers
- 8 Jan 21 Regulation FD Disclosure
- 6 Jan 21 NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
- 2 Sep 20 NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
- 18 Jun 20 Submission of Matters to a Vote of Security Holders
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…